Adial Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
All right. Welcome to the Jefferies 2023 Healthcare Conference. It's my pleasure today to introduce to you Cary Claiborne of Adial Pharmaceuticals. Thank you so much for being here today.
Thanks a lot. Thanks for having me. Good afternoon, everyone. Before I begin, let me remind you that this presentation will include forward-looking statements, so I encourage you to review our filings with the SEC.
So Adial Pharmaceuticals is a clinical-stage biopharma company focused on treating addictions. Our lead focus is for the prevention of alcohol use disorder, also known as AUD. Alcohol use disorder is a large unmet public health need in the United States. There are 35 million people estimated to suffer from alcohol use disorder. It is the leading cause of death for people aged 15 to 49. It contributes to over 200 different diseases, and it costs the US economy, approximately $250 billion per year.
Despite these enormous costs, just over 7% of the people suffering from alcohol use
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
